# September 12 board-content expansion: editorial review

## Authority and status

The owner requested another 20 concept groups and delegated creation, review,
and implementation. Agent editorial acceptance is separate from named-clinician
approval. All new clinical records remain `needs_clinician_review`, with null
clinician sign-off, in the explicitly unapproved prototype.

Target: 20 independently scored concepts, four question variants per concept,
80 question variants and 40 two-node encounters across ten patient families.
Each encounter includes a purposeful diagnostic service and returned findings.

All twenty concepts have passed root editorial review after corrections to
test timing, source links, patient wording, answer choices and requested studies.
The two authoring milestones passed eleven focused tests and clinical-content
typechecks. Integration and browser acceptance are complete. The final evidence
and exact accepted source hashes are recorded below.

## Curriculum provenance

Coverage source: SCORE, *General Surgery Curriculum Outline, 2025–2026*, public
[official outline](https://absprodeus2scorestor.blob.core.windows.net/score/curriculumoutline_gs.pdf),
accessed September 12, 2026. Its verified SHA-256 is
`2b98112b218e0b612fe6ea2f8ad5cf7c6f4555d79289c2f569234aa6b5748c09`.
Locators below are printed/physical PDF pages. This is curriculum alignment,
not a prediction of examination frequency. Diagnostic and management details
are inferred within the named family or procedure and separately sourced.
No proprietary SCORE module or exam question was used.

| Two-concept family | Exact SCORE topic and depth | Locator |
| --- | --- | --- |
| FAP genetic evaluation and rectal-burden surgical planning | Polyposis Syndromes; Total and Subtotal Colectomy — Common | 7/8 |
| Recurrent complex fistula mapping and staged treatment | Anorectal Abscess and Fistulae; Fistula Repair — Common | 8/9 |
| Recovered diverticulitis colon evaluation and elective discussion | Diverticulitis; Partial Colectomy — Common | 7/8 |
| Anal-canal lesion diagnosis/staging and SCC treatment referral | Anal Cancer — Common | 8/9 |
| Postoperative DVT evaluation and finite anticoagulation | Evaluation of the Swollen Leg; Venous Thromboembolism — Common | 15/16 |
| Persistent ITP secondary-cause evaluation and splenectomy timing | Hematologic Diseases of the Spleen; Splenectomy and Splenorrhaphy — Common | 5/6 |
| Gastric GIST tissue/genotype evaluation and selected neoadjuvant treatment | Gastrointestinal Stromal and Neuroendocrine Tumors and Lymphomas — Common | 6/7 |
| Hepatic adenoma characterization and male-patient resection referral | Primary Hepatic Neoplasms — Common | 4/5 |
| Chronic mesenteric ischemia imaging and vascular referral | Procedures for Mesenteric Occlusive Disease — Uncommon | 15/16 |
| Primary aldosteronism biochemical evaluation and localization | Primary Aldosteronism — Common; Adrenalectomy — Uncommon | 10/11 |

Chronic mesenteric ischemia has an inferred relationship to the explicitly
Uncommon procedure. It is not mapped to the separate acute ischemia topic.
ABS exam-context sources and distinct exam scopes are documented in
[BOARD_CONTENT_SCOPE.md](../BOARD_CONTENT_SCOPE.md).

## Sheet and clinical-source review

The live Gamify Surgery Concepts sheet was read through the native connector
on September 12: Sheet1 A1:B200, populated through row 158, and bounded GIST
detail A103:H105. The sheet is a candidate list; no source material was copied
wholesale or edited. Most selected families fill additional curriculum gaps.

Source metadata, evidence boundaries and actual access limitations are in:

- [Colorectal source review](../../execplans/concept-expansion-colorectal-sources-2026-09-12.md)
- [GIST, liver, vascular and endocrine source review](../../execplans/concept-expansion-complex-sources-2026-09-12.md)
- [DVT and ITP source review](../../execplans/concept-expansion-hematology-sources-2026-09-12.md)

The GIST sheet suggestion was narrowed to a mutation-sensitive tumor for which
shrinkage can reduce operative morbidity. Current ASH 2026 ITP guidance governs
splenectomy timing; retired 2019 drug-ranking recommendations were not adopted.
The aldosteronism case uses a source-bounded overt biochemical phenotype after
appropriate preparation, rather than treating every elevated screening ratio
as confirmation. Negative HIV/HCV testing alone does not establish primary ITP.

## Editorial and simulation boundaries

Generated patient identities and clinically constrained profiles remain in the
existing generator. Findings are delivered through result gates. All test-bearing
alternatives, including surveillance and marrow evaluation, receive neutral
game-time estimates. Non-test alternatives in mixed nodes show No test wait.
Simulation durations and profile values are not clinical turnaround promises,
epidemiologic weights or new diagnostic thresholds.

External specialist pathways do not imply the clinic can perform cancer
therapy, advanced endocrine localization or major surgery onsite. The batch
does not diagnose or claim to fix the separately reported day-six patient
shortage. Existing stable IDs, frozen saves and prior review receipts remain
preserved.

## Final validation

All 1,029 affected-package tests pass: clinical-content 332, game-domain 258,
player 427 and balance 12. All40 new encounters completed their real result
gates with one FSRS review per concept; wrong-answer continuation and pending
serialization checks pass. The full build, seven workspace typechecks and
runtime dependency/launcher boundary checks pass. Existing bundle-size and
build-plugin timing advisories remain.

The full content suite exposed longest-key and patient-narrative issues that
were corrected before acceptance; no new legacy exceptions were added. The
domain suite passed with one worker after an older September10 monolithic test
timed out under parallel load. No test time-limit waiver was introduced.

Two isolated desktop Chrome scenarios passed together at exactly
http://127.0.0.1:4173 (3.7 minutes): postoperative DVT admission, complete timing,
pending reload, return and completion; and anal-lesion wrong-answer correction,
combined biopsy/staging wait, returned findings and final referral. Root
inspected the final spec, logs and six screenshots. The anal returned screenshot
shows expanded completed-decision history; browser assertions separately verify
the single current-update panel, its text and final completion. Test fixtures
seed reducer-generated automatic arrivals into fresh test storage and do not
establish long-term arrival sustainability.

Terra authored twelve concepts and the dated helper, and added the initial
registry seams. Sol authored eight concepts, completed service/admission/domain
integration, corrected review findings and authored the browser fixtures. Astra
reviewed actual authored content and shared-file diffs, ran full regression,
build and browser acceptance, and inspected screenshots. All implementation
milestones were delegated; root retained planning and acceptance.

The temporary Vite test server was stopped after validation. The owner pathway
remains START_GAME.cmd at the canonical local origin in the usual persistent
browser profile. No owner save reset, dependency installation, commit, push,
publication or deployment occurred. This is a local, unpushed checkpoint;
the owner can request an audited backup by saying **"push to GitHub"**.

Validation logs are under `.local-dev/board-expansion-2026-09-12/logs/`.
The final browser log is `browser-final.log`; final domain regression is
`full-game-domain-serial-final.log`. Earlier failed logs are preserved and
superseded by the final passing runs.

## Ordered concept IDs and source hashes

1. `concept.fap.germline-testing-after-diffuse-adenomas`
2. `concept.fap.ipaa-for-uncontrolled-rectal-burden`
3. `concept.complex-perianal-fistula.mri-mapping`
4. `concept.complex-perianal-fistula.loose-seton-staged-planning`
5. `concept.recovered-diverticulitis.interval-colonoscopy`
6. `concept.recovered-diverticulitis.shared-elective-sigmoid-discussion`
7. `concept.anal-scc.biopsy-and-staging`
8. `concept.anal-scc.localized-chemoradiation-referral`
9. `concept.postoperative-dvt.venous-duplex`
10. `concept.postoperative-dvt.three-month-anticoagulation`
11. `concept.persistent-itp.hiv-hcv-secondary-evaluation`
12. `concept.persistent-itp.defer-elective-splenectomy`
13. `concept.gastric-gist.eus-core-molecular-diagnosis`
14. `concept.gastric-gist.mutation-guided-neoadjuvant-imatinib`
15. `concept.hepatic-adenoma.multiphasic-mri-characterization`
16. `concept.hepatic-adenoma.resection-in-men`
17. `concept.chronic-mesenteric-ischemia.cta-diagnosis`
18. `concept.chronic-mesenteric-ischemia.revascularization-referral`
19. `concept.primary-aldosteronism.prepared-arr-screening`
20. `concept.primary-aldosteronism.ct-avs-lateralization`

These LF-normalized hashes bind the accepted final source versions.

| LF-normalized SHA-256 | Production TypeScript source |
| --- | --- |
| `408e057dafe53a9b1357ce8dabdbaed587be20e7f3ad3626df38873d850a7ff2` | `packages/clinical-content/src/development-batch/2026-09-12/batch-helpers.ts` |
| `0169ff81d128d31019f1b6dca62d9b53b06e2644d2864fb169c95091c3db7f6c` | `packages/clinical-content/src/development-batch/2026-09-12/familial-adenomatous-polyposis.ts` |
| `093a3aa0532eaabc64e1a69576f166205180dee1e90b9b75325ed03e4489b719` | `packages/clinical-content/src/development-batch/2026-09-12/complex-perianal-fistula.ts` |
| `f3fa1f1192426944a541048ddc9365b341c9fbd5927ebdef712a32d9a8c5b0d4` | `packages/clinical-content/src/development-batch/2026-09-12/recovered-diverticulitis.ts` |
| `4f73a82365e96e516b3bb478379287e4138532852baef92f4ed89b5a31c29e68` | `packages/clinical-content/src/development-batch/2026-09-12/anal-squamous-cell-cancer.ts` |
| `6dab181cb1891e25374c74fe7254d696209c4c061210f6e91bbc4109c8723c63` | `packages/clinical-content/src/development-batch/2026-09-12/postoperative-dvt.ts` |
| `6762cd787fced0d83cc8dd58f43f70d506d5ce70fa202377246a72ee3aa7bd77` | `packages/clinical-content/src/development-batch/2026-09-12/persistent-itp.ts` |
| `22ab76777c788ca11188774a16d0bedb23f72b4ea9fc83f5c1e01a438d0fbbe1` | `packages/clinical-content/src/development-batch/2026-09-12/gastric-gist.ts` |
| `5dbad67c8797de4519c1b118ca3f9cc5c1cc067a7255c9b663759b75a7c71dd3` | `packages/clinical-content/src/development-batch/2026-09-12/hepatic-adenoma.ts` |
| `871d668d084050cf8d96f652cb2a94035aebbeee1864fdd51f466d6ac9c06917` | `packages/clinical-content/src/development-batch/2026-09-12/chronic-mesenteric-ischemia.ts` |
| `490e2980df24ade0cd63cabd66aaed632083e12ef1a22506d611d80bdb51ddb6` | `packages/clinical-content/src/development-batch/2026-09-12/primary-aldosteronism.ts` |
| `c5d197ac06c7bc715e5433c79938296ebb181e07f0e61098e41cd7fee7a3a3bd` | `packages/clinical-content/src/development-batch/2026-09-12/board-expansion-batch.ts` |
